Diagnosis and Treatment of Pulmonary Arterial Hypertension

医学 西地那非 曲前列环素 肺动脉高压 安倍生坦 波生坦 肺动脉 内科学 心脏病学 肺楔压 血管阻力 心力衰竭 环磷酸鸟苷 他达拉非 里奥西瓜特 血压 一氧化氮 内皮素受体 慢性血栓栓塞性肺高压 受体
作者
Nicole F. Ruopp,Barbara A. Cockrill
出处
期刊:JAMA [American Medical Association]
卷期号:327 (14): 1379-1379 被引量:259
标识
DOI:10.1001/jama.2022.4402
摘要

Importance

Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension (PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is approximately 10.6 cases per 1 million adults in the US. Untreated, PAH progresses to right heart failure and death.

Observations

Pulmonary hypertension is defined by a mean pulmonary artery pressure greater than 20 mm Hg and is classified into 5 clinical groups based on etiology, pathophysiology, and treatment. Pulmonary arterial hypertension is 1 of the 5 groups of PH and is hemodynamically defined by right heart catheterization demonstrating a mean pulmonary artery pressure greater than 20 mm Hg, a pulmonary artery wedge pressure of 15 mm Hg or lower, and a pulmonary vascular resistance of 3 Wood units or greater. Pulmonary arterial hypertension is further divided into subgroups based on underlying etiology, consisting of idiopathic PAH, heritable PAH, drug- and toxin-associated PAH, pulmonary veno-occlusive disease, PAH in long-term responders to calcium channel blockers, and persistent PH of the newborn, as well as PAH associated with other medical conditions including connective tissue disease, HIV, and congenital heart disease. Early presenting symptoms are nonspecific and typically consist of dyspnea on exertion and fatigue. Currently approved therapy for PAH consists of drugs that enhance the nitric oxide–cyclic guanosine monophosphate biological pathway (sildenafil, tadalafil, or riociguat), prostacyclin pathway agonists (epoprostenol or treprostinil), and endothelin pathway antagonists (bosentan and ambrisentan). With these PAH-specific therapies, 5-year survival has improved from 34% in 1991 to more than 60% in 2015. Current treatment consists of combination drug therapy that targets more than 1 biological pathway, such as the nitric oxide–cyclic guanosine monophosphate and endothelin pathways (eg, ambrisentan and tadalafil), and has shown demonstrable improvement in morbidity and mortality compared with the previous conventional single-pathway targeted monotherapy.

Conclusions and Relevance

Pulmonary arterial hypertension affects an estimated 10.6 per 1 million adults in the US and, without treatment, typically progresses to right heart failure and death. First-line therapy with drug combinations that target multiple biological pathways are associated with improved survival.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风趣的冬卉完成签到 ,获得积分10
1秒前
李爱国应助ybwei2008_163采纳,获得10
2秒前
wenhuanwenxian完成签到 ,获得积分10
6秒前
spring完成签到 ,获得积分10
9秒前
ding应助sjl采纳,获得10
22秒前
26秒前
ybwei2008_163发布了新的文献求助10
32秒前
home完成签到,获得积分10
37秒前
宇文非笑完成签到 ,获得积分10
42秒前
Dingz完成签到,获得积分10
46秒前
顺利如冰完成签到,获得积分10
46秒前
53秒前
ybwei2008_163发布了新的文献求助10
59秒前
59秒前
没用的三轮完成签到,获得积分10
1分钟前
kais完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
橘子海完成签到 ,获得积分10
1分钟前
sjl发布了新的文献求助10
1分钟前
HC3完成签到 ,获得积分10
1分钟前
稳重岩完成签到 ,获得积分10
1分钟前
wangfneg完成签到 ,获得积分10
1分钟前
Yimi刘博完成签到 ,获得积分10
1分钟前
吴旭东完成签到,获得积分10
1分钟前
任盈盈完成签到,获得积分10
1分钟前
gyx完成签到 ,获得积分10
1分钟前
不辞完成签到 ,获得积分10
1分钟前
twelveyears完成签到 ,获得积分10
1分钟前
2分钟前
大小罐子发布了新的文献求助10
2分钟前
ybwei2008_163完成签到,获得积分20
2分钟前
稻子完成签到 ,获得积分10
2分钟前
团团完成签到 ,获得积分10
2分钟前
2分钟前
S.完成签到 ,获得积分10
2分钟前
isedu完成签到,获得积分10
3分钟前
3分钟前
scenery0510完成签到,获得积分10
3分钟前
小惠完成签到 ,获得积分10
3分钟前
高分求助中
中国国际图书贸易总公司40周年纪念文集 大事记1949-1987 2000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
草地生态学 880
Threaded Harmony: A Sustainable Approach to Fashion 799
Basic Modern Theory of Linear Complex Analytic 𝑞-Difference Equations 510
中国有机(类)肥料 500
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3059677
求助须知:如何正确求助?哪些是违规求助? 2715529
关于积分的说明 7445380
捐赠科研通 2361205
什么是DOI,文献DOI怎么找? 1251238
科研通“疑难数据库(出版商)”最低求助积分说明 607711
版权声明 596467